Steno Institute is a 501(c)(3) public benefit corporation
Initial research will focus on the reversal of mifepristone abortions, the most common type of medical abortion in the United States and other Western countries. To date, Dr. Delgado’s research in this area (authorship or co-authorship) includes three articles on abortion pill reversal in the peer reviewed medical literature. His latest article details 261 successful mifepristone reversal cases. However, to convince the healthcare community of the efficacy and safety of abortion pill reversal, Dr. Delgado is designing a clinical randomized control trial (RCT) study; it will compare leading progesterone protocols regarding efficacy and side effects to determine the best reversal method.
This would be a key study since no antidote currently exists. In some countries, the use of misoprostol alone for medical abortion is widespread.
The same study above will examine the psychology of women and couples regarding crisis pregnancy choices and assist counselors in their work.
Knowing whether or not early involvement of fathers of preborn babies in pregnancy resource center counseling affects women’s choices in crisis pregnancy is key to directing future strategies.
Methotrexate, primarily used to treat ectopic pregnancy, is used occasionally to abort intrauterine pregnancies. Data on some methotrexate reversal cases have already been collected.
Research Results
Research Results will provide expanded and definitive clinical answers related to the effectiveness and safety of abortion pill reversal, identification of the most successful clinical protocols for abortion pill reversal, identification of the most successful intervention techniques for crisis pregnancies, expanded data on the physical and psychological impacts of abortion and the best techniques for healing, the relationship of contraceptive medications and abortions and some forms of cancer, and the risks of euthanasia and physician assisted suicide.
Improved Medical Care for Abortion Pill Reversal and Increased Access for Women
Steno Institute research, which would cement the safety and effectiveness of mifepristone abortion reversal in the opinion of the medical community, will expand women’s choice and ensure more women have access to reversal treatment in medical offices, clinics and emergency rooms. Moreover, further research will demonstrate safe and effective ways to reverse other types of medication abortion. Ultimately, the Institute may contribute to the universal acknowledgement and acceptance of medication abortion reversal.
